SCIENTIFIC HUB

Follow the evidence.

15.306 articles found

Open access

Efficacy and feasibility of virtual reality-based cognitive tele-rehabilitation in Parkinson's disease: A pilot randomized controlled trial on patients and caregivers.

Maggio MG, Rizzo A, Benenati A, Giambò Mauro F, Cannavò A, De Pasquale P, De Luca R, Quartarone A, Calabrò RS.

Digit Health · 2025-01-01

DOI: 10.1177/20552076251376534PMID: 41018508

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Statins as potential disease-modifying therapy of Parkinson's disease: a systematic review and meta-analysis with trial sequential analysis.

Gonçalves OR, Nascimento AB, Soares VG, Abraham D, de Almeida Monteiro G, Freitas JLR, da Cunha Monteiro Ribeiro JP, Ribeiro BL, de Oliveira JVA, Dos Santos MAR, Telles JPM, Sekeff-Sallem F, Almeida KJ.

Acta Neurol Belg · 2024-12-30

DOI: 10.1007/s13760-024-02709-4PMID: 39738967

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Creatine Supplementation Beyond Athletics: Benefits of Different Types of Creatine for Women, Vegans, and Clinical Populations-A Narrative Review.

Gutiérrez-Hellín J, Del Coso J, Franco-Andrés A, Gamonales JM, Espada MC, González-García J, López-Moreno M, Varillas-Delgado D.

Nutrients · 2024-12-29

DOI: 10.3390/nu17010095PMID: 39796530

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data.

Nikolcheva T, Pagano G, Pross N, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Seppi K, Monnet A, Shariati N, Ricci B, Rutten-Jacobs L, Respondek G, Kustermann T, Taylor KI, Trundell D, Fontoura P, Doody R, Svoboda H, Bonni A, PADOVA Investigators and Prasinezumab Study Group.

Parkinsonism Relat Disord · 2024-12-29

DOI: 10.1016/j.parkreldis.2024.107257PMID: 39798255

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies.

Devos D, Rascol O, Meissner WG, Foubert-Samier A, Lewis S, Tranchant C, Anheim M, Maltête D, Remy P, Eggert K, Pape H, Geny C, Couratier P, Carroll C, Sheridan R, Burn D, Pavese N, Raw J, Berg D, Suchowersky O, Kalia LV, Evans A, Drapier S, Danaila T, Schnitzler A, Corvol JC, Defer G, Temin NT, Fradette C, Tricta F, Moreau C, a Parkinson's disease study group.

J Parkinsons Dis · 2024-12-27

DOI: 10.1177/1877718x241300295PMID: 39973479

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.